Share on StockTwits

Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio unloaded 2,000 shares of Illumina stock on the open market in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $174.26, for a total value of $348,520.00. Following the completion of the sale, the senior vice president now directly owns 23,146 shares of the company’s stock, valued at approximately $4,033,422. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Illumina (NASDAQ:ILMN) traded down 0.38% during mid-day trading on Wednesday, hitting $171.09. The stock had a trading volume of 967,079 shares. Illumina has a 1-year low of $72.77 and a 1-year high of $184.49. The stock has a 50-day moving average of $170.7 and a 200-day moving average of $153.5. The company has a market cap of $21.968 billion and a P/E ratio of 120.77.

Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, April 22nd. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter last year, the company posted $0.46 earnings per share. Illumina’s revenue was up 27.2% compared to the same quarter last year. On average, analysts predict that Illumina will post $2.17 earnings per share for the current fiscal year.

A number of research firms have recently commented on ILMN. Analysts at Zacks upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Tuesday, June 24th. They now have a $205.00 price target on the stock. Separately, analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Finally, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Six investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $150.97.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.